脂质微球用于局部输送诺夫洛克萨:开发和评估
Aruna Murugan1, Niserga Sawant1, Vasanti Suvarna2
1C. U. Shah College of Pharmacy, SNDT Women's University, Sir Vithaldas Vidyavihar, Santacruz [W], Mumbai - 400 049, Maharashtra, India.
Recent advances in drug delivery and formulation
|April 29, 2025
概括
局部凝中的诺夫洛克萨脂微球通过提高药物可用性和延长释放,提供了改善的烧伤治疗. 为了临床应用,需要进行进一步的研究.
科学领域:
- 药品制造 药品制造 药品制造
- 药物输送系统 药物输送系统
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 烧伤带来复杂的临床挑战,特别是潮湿,热凝结的伤害.
- 有效的局部抗微生物药物供应对于管理烧伤感染和促进愈合至关重要.
研究的目的:
- 开发和评估纳弗洛克萨纳脂微球纳入局部凝.
- 为了提高诺夫洛克萨在烧伤管理中的辅助治疗的治疗效果.
主要方法:
- 使用溶解扩散技术制备了装有诺夫洛克萨的脂质微球.
- 微球的特点是尺寸,形态 (SEM) 和药物捕获.
- 用Carbopol 971P NF制成局部凝,用于药物释放和皮肤透研究.
主要成果:
- 脂质微球显示出最佳尺寸 (65.22微米) 和高药物捕获率 (81.58%).
- 实验室研究表明,诺夫洛克萨从微球和凝中持续释放8小时.
- 活体研究证实诺夫洛克萨通过烧伤和完整的猪皮肤透,具有增强的抗菌活性.
结论:
- 局部凝中的诺夫洛克萨脂微球显示出改善烧伤管理的潜力.
- 该配方增强了药物的溶解性,提供延长释放,并促进局部递送.
- 进一步的临床前和临床评估是必要的,以确认治疗效用和探索更广泛的应用.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.9K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.9K
Bioavailability Enhancement: Drug Permeability Enhancement
360
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
360
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167


